We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 33 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. null/null
  3. スペラファーマ Osaka//others
  4. 4 null/null
  5. 5 立山化成 Toyama//Manufacturing and processing contract
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

  1. [Research Material] The Global Market for Neglected Tropical Disease (NTD) Treatments マーケットリサーチセンター
  2. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  3. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. Tateyama Kasei Co., Ltd. Kyushu Factory 立山化成

medicine Product List

136～150 item / All 593 items

Displayed results
[Research Material] The Global Market for Cushing's Syndrome Treatment

[Research Material] The Global Market for Cushing's Syndrome Treatment

World Market for Cushing's Syndrome Treatment: Glucocorticoid Receptor Inhibitors, Somatostatin, Ketoconazole HRA, Others, Hospital Pharmacies, Small ...

This research report (Global Cushing's Syndrome Treatment Market) investigates and analyzes the current status and outlook for the global market for Cushing's syndrome treatment over the next five years. It includes information on the overview of the global Cushing's syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Cushing's syndrome treatment market include glucocorticoid receptor antagonists, somatostatin, ketoconazole HRA, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Cushing's syndrome treatment. It also includes the market share of major companies in the Cushing's syndrome treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Trigeminal Neuralgia Treatment Drugs

[Research Material] Global Market for Trigeminal Neuralgia Treatment Drugs

Global Market for Trigeminal Neuralgia Treatment Drugs: Carbamazepine, Oxcarbazepine, Others, Hospitals, Clinics, Others

This research report (Global Trigeminal Neuralgia Treatment Medicine Market) investigates and analyzes the current status and outlook for the global market for trigeminal neuralgia treatment medications over the next five years. It includes information on the overview of the global trigeminal neuralgia treatment medication market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include carbamazepine, oxcarbazepine, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for trigeminal neuralgia treatment medications. It also includes the market share of major companies in the trigeminal neuralgia treatment medication sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for mRNA Vaccines and Therapeutics

[Research Material] Global Market for mRNA Vaccines and Therapeutics

Global Market for mRNA Vaccines and Therapeutics: Infectious Disease Vaccines, Cancer Vaccines, Infectious Diseases, Cancer, Others

This research report (Global mRNA Vaccines & Therapeutics Market) investigates and analyzes the current state and future outlook of the global mRNA vaccine and therapeutic market over the next five years. It includes information on the overview of the global mRNA vaccine and therapeutic market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on infectious disease vaccines and cancer vaccines, while the segments by application target infectious diseases, cancer, and others. The regional segments calculate the market size of mRNA vaccines and therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the mRNA vaccine and therapeutic market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Materials] Global Market for Treatment Drugs for Muscular Dystrophy

[Research Materials] Global Market for Treatment Drugs for Muscular Dystrophy

Global Market for Treatment Drugs for Myotonic Dystrophy: ISIS-DMPKRx, PRO-135, SRT-152, VAL-0411, and others...

This research report (Global Myotonic Dystrophy Drug Market) investigates and analyzes the current state and outlook for the global market for myotonic dystrophy treatments over the next five years. It includes information on the overview of the global myotonic dystrophy drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis, among other details. The market segments by type include ISIS-DMPKRx, PRO-135, SRT-152, VAL-0411, and others, while the segments by application focus on hospitals, clinics, home care, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for myotonic dystrophy treatments. It also includes the market share of major companies in the myotonic dystrophy drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rare Disease Treatments

[Research Material] Global Market for Rare Disease Treatments

Global Market for Rare Disease Treatments: Originator Drugs, Generic Drugs, Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies

This research report (Global Rare Disease Treatment Market) investigates and analyzes the current state of the global market for rare disease treatments and its outlook for the next five years. It includes information on the overview of the global rare disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rare disease treatment market focus on originator drugs and generic drugs, while the segments by application target hospital pharmacies, specialty pharmacies, and retail pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for rare disease treatments. It also includes the market share of major companies in the rare disease treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Autoimmune Hepatitis Treatment

[Research Material] Global Market for Autoimmune Hepatitis Treatment

Global Market for Autoimmune Hepatitis Treatment: Tablets, Injections, Others, Hospitals, Clinics, Others

This research report (Global Autoimmune Hepatitis Treatment Market) investigates and analyzes the current status and outlook for the global autoimmune hepatitis treatment market over the next five years. It includes information on the overview of the global autoimmune hepatitis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by key regions, and distribution channel analysis. The segments of the autoimmune hepatitis treatment market by type include tablets, injectables, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for autoimmune hepatitis treatment. It also includes the market share of major companies in autoimmune hepatitis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for White Matter Injury Treatment

[Research Material] Global Market for White Matter Injury Treatment

Global Market for White Matter Injury Treatment: Drug Therapy, Palliative Care, Hospitals, Emergency Centers, Outpatient Surgery Centers, Others

This research report (Global White Matter Injury Treatment Market) investigates and analyzes the current status and outlook for the global market for white matter injury treatment over the next five years. It includes information on the overview of the global white matter injury treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include drug treatment and palliative care, while the segments by application focus on hospitals, emergency centers, outpatient surgery centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for white matter injury treatment. It also includes the market share of major companies in white matter injury treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatments of Nasopharyngeal Cancer

[Research Material] Global Market for Treatments of Nasopharyngeal Cancer

World Market for Oropharyngeal Cancer Treatments: BGBA317, CBT501, Apatinib, APG1387, ARGX110, ATA129, and others...

This research report (Global Nasopharyngeal Cancer Drug Market) investigates and analyzes the current status and outlook for the global market of nasopharyngeal cancer treatments over the next five years. It includes information on the overview of the global nasopharyngeal cancer drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include BGBA317, CBT501, Apatinib, APG1387, ARGX110, ATA129, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for nasopharyngeal cancer treatments. It also includes the market share of major companies in the nasopharyngeal cancer drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Epidermolysis Bullosa Treatment Drugs

[Research Material] Global Market for Epidermolysis Bullosa Treatment Drugs

Global Market for Epidermolysis Bullosa Treatment Drugs: EB-201, FCX-007, ICX-RHY, INM-750, Others, Clinics, Hospitals, Others

This research report (Global Epidermolysis Bullosa Therapeutics Market) investigates and analyzes the current status and future outlook of the global market for epidermolysis bullosa therapeutics over the next five years. It includes information on the overview of the global epidermolysis bullosa therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include EB-201, FCX-007, ICX-RHY, INM-750, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for epidermolysis bullosa therapeutics. It also includes the market share of major companies in the epidermolysis bullosa therapeutics sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Materials] Global Market for Purpura Treatment Drugs

[Research Materials] Global Market for Purpura Treatment Drugs

World Market for Purpura Treatments: Allergic Purpura, Thrombocytopenic Purpura, Hospital Use, Clinic Use, Home Use, Others

This research report (Global Purpura Therapy Drugs Market) investigates and analyzes the current status and outlook for the global market of purpura treatment drugs over the next five years. It includes information on the overview of the global purpura treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on allergic purpura and thrombocytopenic purpura, while the segments by application target hospitals, clinics, home use, and others. The regional segments calculate the market size of purpura treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in purpura treatment drugs, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Knee Treatment in Athletes

[Research Material] Global Market for Knee Treatment in Athletes

World Market for Athlete Knee Treatments: Corticosteroids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Hyaluronic Acid, Others, Hospitals, Clinics ...

This research report (Global Athletic Knee Treatment Market) investigates and analyzes the current state and outlook for the global market for athlete knee treatments over the next five years. It includes information on the overview of the global athlete knee treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), hyaluronic acid, and others, while the segments by application cover hospitals, clinics, outpatient surgery centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for athlete knee treatments. It also includes the market share of major companies in athlete knee treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rheumatic Disease Therapeutics

[Research Material] Global Market for Rheumatic Disease Therapeutics

World Market for Rheumatic Disease Therapeutics: Tumor Necrosis Factor-α Inhibitors, Interleukin and Interleukin Receptor Inhibitors, Protein Kinase ...

This research report (Global Rheumatic Disorders Drug Market) investigates and analyzes the current state and outlook for the global market for rheumatic disease treatment drugs over the next five years. It includes information on the overview of the global rheumatic disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rheumatic disease treatment drug market include tumor necrosis factor-alpha inhibitors, interleukin and interleukin receptor inhibitors, protein kinase inhibitors, cell surface antigen inhibitors, hormone and hormone receptor inhibitors, and others. The segments by application include rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus, psoriatic arthritis, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for rheumatic disease treatment drugs. It also includes the market share of major companies in the rheumatic disease treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Document] Global Market for Treatment Drugs for Undifferentiated Large Cell Lymphoma

[Research Document] Global Market for Treatment Drugs for Undifferentiated Large Cell Lymphoma

World Market for Undifferentiated Large Cell Lymphoma Treatment Drugs: Oral, Injection, Hospitals, Drugstores, Others

This research report (Global Anaplastic Large Cell Lymphoma Drugs Market) investigates and analyzes the current status and outlook for the global market of anaplastic large cell lymphoma treatment drugs over the next five years. It includes information on the overview of the global anaplastic large cell lymphoma treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis, among other details. The market segments by type focus on oral and injectable forms, while the segments by application target hospitals, drugstores, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for anaplastic large cell lymphoma treatment drugs. It also includes the market share of major companies in the anaplastic large cell lymphoma treatment drugs sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Primary Sclerosing Cholangitis Treatment

[Research Material] Global Market for Primary Sclerosing Cholangitis Treatment

Global Market for Primary Sclerosing Cholangitis Treatment: Liver Transplant Surgery, UDCA Drugs, PSC Drugs, Hospitals, Clinics, Others

This research report (Global Primary Sclerosing Cholangitis Treatment Market) investigates and analyzes the current state and outlook for the global market for primary sclerosing cholangitis treatment over the next five years. It includes information on the overview of the global primary sclerosing cholangitis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the primary sclerosing cholangitis treatment market focus on liver transplant surgery, UDCA drugs, and PSC drugs, while the segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for primary sclerosing cholangitis treatment. It also includes the market share of major companies in primary sclerosing cholangitis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for the Treatment of Tardive Dyskinesia (TD)

[Research Material] The Global Market for the Treatment of Tardive Dyskinesia (TD)

World Market for the Treatment of Tardive Dyskinesia (TD): Valbenazine, Amantadine, Tetrabenazine, Clonazepam, Others, Hospitals, Clinics, Others

This research report (Global Tardive Dyskinesia (TD) Treatment Market) investigates and analyzes the current state and future outlook of the global market for tardive dyskinesia (TD) treatment over the next five years. It includes information on the overview of the global tardive dyskinesia (TD) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include valbenazine, amantadine, tetrabenazine, clonazepam, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for tardive dyskinesia (TD) treatment. It also includes the market share of major companies in the tardive dyskinesia (TD) treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.